Skip to Content

Agenda Information

The University of Texas M. D. Anderson Cancer Center and
M. D. Anderson Physicians Network

Continuing Medical Education
July 11–14, 2009
Fifth Annual Symposium:
Update on Personalized Medicine and Multidisciplinary Cancer Therapy

July 11–14, 2009

Update on Personalized Medicine and Multidisciplinary Cancer Therapy

 

 

Saturday, July 11, 2009

 

 

Gastrointestinal Cancers - Program Co-Chair: James L. Abbruzzese, MD

 

 

6:30-7:00 a.m.

Continental Breakfast/Registration

 

 

7:00-7:15

Introduction and Welcome - Waun K. Hong, MD, William J. Simeone, Jr., MHA

 

 

7:15-7:55

Keynote Speaker - James L. Abbruzzese, MD
Genetic Blueprint for Pancreatic Cancer: Opportunities for Therapeutic Development

 

 

7:55-8:20

Contemporary Management of Advanced Colorectal Cancer
Scott Kopetz, MD

 

 

8:20-8:45

Surgical Management of Colorectal Hepatic Metastases
Eddie K. Abdalla, MD

 

 

8:45-9:10

Novel Targets and Innovative Clinical Trials Design for Advanced Colorectal Cancer
Scott Kopetz, MD

 

 

9:10-9:20

Break

 

 

9:20-9:45

Update on Neoadjuvant and Adjuvant Therapy in the Treatment of Pancreatic Cancer
Gauri R. Varadhachary, MD

 

 

9:45-10:10

Management of Borderline Resectable Pancreatic Cancer
Gauri R. Varadhachary, MD

 

 

10:10-10:35

The Role of Proton Beam Therapy in the Treatment of Gastrointestinal Cancers
Prajnan Das, MD, MS, MPH

 

 

10:35-10:45

Break

 

 

10:45-11:15

Challenging Gastrointestinal Cancer Cases Presentation and Interactive Audience Participation
Moderator: Alexandria Phan, MD
Gastrointestinal Faculty Speakers

 

 

 

 

11:15-11:25

Break and Pick Up Box Lunch

 

 

Gynecologic Cancers - Program Co-Chair: David M. Gershenson, MD

 

 

11:25-11:30

Introduction - David M. Gershenson, MD

 

 

11:30-11:55

Contemporary Management of Primary Epithelial Ovarian Cancer
Robert Coleman, MD

 

 

11:55-12:20 p.m.

Update on Management of Recurrent Epithelial Ovarian Cancer
Maurie Markman, MD

 

 

12:20-12:45

Updates in the Surgical Management of Advanced Ovarian Cancer
Pedro T. Ramirez, MD

 

 

12:45-1:10

New Developments in Therapy for Uncommon Ovarian Tumors
Jubilee Brown, MD

 

 

1:10-1:35

Contemporary Management of Cervical and Uterine Malignancies
Lois M. Ramondetta, MD

 

 

1:35-2:00

Challenging Gynecologic Oncology Cases Presentation and Interactive Audience Participation
Moderator: David M. Gershenson, MD
Gynecologic Oncology Faculty Speakers

 

 

2:00

Adjourn

 

 

6:30-8:30 p.m.

Welcome Reception - Terrace

 

 

Sunday, July 12, 2009

 

 

Genitourinary Cancers - Program Co-Chair: Richard J. Babaian, MD

 

 

6:45-7:15 a.m.

Continental Breakfast/Registration

 

 

7 :15-7:20

Introduction - Richard J. Babaian, MD

 

 

Prostate Cancer

 

 

7:20-7:40

Technical and Treatment Parameters for IMRT and Brachytherapy
Deborah A. Kuban, MD

 

 

7:40-8:00

Proton Therapy: Is It Worth It?
Deborah A. Kuban, MD

 

 

8:00- 8:15

Evaluation and Treatment Considerations for Rising PSA Following Definitive Therapy
John W. Davis, MD

 

 

8:15-8:30

New Frontiers in the Management of Metastatic Prostate Cancer: Are We Making Progress?
Paul Mathew, MD

 

 

8:30-8:45

Break

 

 

Testicular Cancer

 

 

8:45-9:10

Current Approach to Management of Stage I Testicular Cancer: Surgical and Medical Perspective
John W. Davis, MD and Paul Mathew, MD

 

 

9:10-9:30

Therapeutic Strategies for Metastatic Testicular Cancer
Paul Mathew, MD

 

 

Bladder Cancer

 

 

9:30-9:50

Is There a Role for Neoadjuvant or Adjuvant Therapy for High Risk Disease?
Eric Jonasch, MD

 

 

9:50-10:10

Update on the Treatment of Metastatic Bladder Cancer
Eric Jonasch, MD

 

 

10:10-10:25

Break

 

 

Renal Cell Cancer

 

 

10:25-10:45

Targeted Therapy Before or After Surgery
Eric Jonasch, MD

 

 

10:45-11:15

Challenging Genitourinary Cases Presentation and Interactive Audience Participation
Moderator: Richard J. Babaian, MD
Genitourinary Faculty Speakers

 

 

11:15-11:30

Break and Pick Up Box Lunch

 

 

Lymphoma Program - Program Co-Chair: Peter McLaughlin, MD

 

 

1 1:30-11:35

Introduction - Peter McLaughlin, MD

 

 

11:35-11:45

Follicular Lymphoma: Introduction
Peter McLaughlin, MD

 

 

11:45-12:05 p.m.

Follicular Lymphoma: Rethinking Vaccine Strategies
Sattva S. Neelapu, MD

 

 

12:05-12:15

Diffuse Large B-cell Lymphoma: Background
Peter McLaughlin, MD

 

 

12:15-12:35

Diffuse Large B-cell Lymphoma: New Therapeutic Targets
R. Eric Davis, MD

 

 

12:35-1:00

Current Management of Mantle Cell Lymphoma
Jorge E. Romaguera, MD

 

 

1:00-1:30

Stem Cell Transplant: The Graft Versus Lymphoma Effect
Richard E. Champlin, MD

 

 

1:30-2:00

Challenging Lymphoma Cases Presentation and Interactive Audience Participation
Moderator: Peter McLaughlin, MD
Lymphoma Faculty Speakers

 

 

2:00

Adjourn

 

 

Monday, July 13, 2009

 

 

Thoracic Cancers - Program Co-Chair: Daniel D. Karp, MD

 

 

6:45-7:15 a.m.

Continental Breakfast/Registration

 

 

7:15-7:20

Introduction - Daniel D. Karp, MD

 

 

7:20-7:50

Enhancing the Staging System: Prognostic Models and Factors Associated with Long-Term Survival
Daniel D. Karp, MD

 

 

7:50-8:20

Imaging Studies: The Foundation of Individualized Lung Cancer Treatment
Jeremy Erasmus, Jr., MD

 

 

8:20-8:50

Preserving Lung Function with Advanced Radiation Techniques
James D. Cox, MD

 

 

8:50-9:20

New Strategies for Surgical Management Curative Tactics for Regionally Advanced and Oligometastatic Disease
Stephen G. Swisher, MD

 

 

9:20 -9:35

Break

 

 

9:35-10:05

Genomic Determinants of Response in Advanced Lung Cancer
Bruce E. Johnson, MD

 

 

10:05-10:35

Changing Paradigms in Advanced Non-Small Cell Lung Cancer: How Can We Tailor Patient Therapy?
Edward S. Kim, MD

 

 

10:35-11:15

Challenging Thoracic Cases Presentation and Interactive Audience Participation
Moderator: Daniel D. Karp, M
Thoracic Faculty Speakers

 

 

11:15-11:30

Break and Pick Up Box Lunch

 

 

Head and Neck Cancers - Program Co-Chair: Bonnie S. Glisson, MD

 

 

11:30-11:35

Introduction - Bonnie S. Glisson, MD

 

 

11:35-12:05 p.m.

HPV as a Predictive/Prognostic Factor in Patients Treated With Sequential Chemoradiation: The TAX 324 Experience
Marshall R. Posner, MD

 

 

12:05-12:35

Radiation and Chemoradiation for Patients With Advanced Head And Neck Cancer: Integration of Personalized Approaches
Steven J. Frank, MD

 

 

12:35-1:00

Chemotherapy as Definitive Treatment for Larynx Cancer: The Contribution of Gene Expression Profiling to Prognostication and Prediction
F. Christopher Holsinger, MD

 

 

1:00-1:30

Emerging Concepts in Protein Profiling of Head and Neck Cancer: Patients, Cell Lines and Their Intersection
Lauren A. Byers, MD

 

 

1:30-2:00

Challenging Head and Neck Cases Presentation and Interactive Audience Participation
Moderator: Bonnie S. Glisson, MD
Head and Neck Faculty Speakers

 

 

2:00-3:00

Meet the Professors - All Faculty

 

 

3:00

Adjourn

 

 

Tuesday, July 14, 2009

 

 

Breast Cancer - Program Co-Chair: Kelly K. Hunt, MD

 

 

6:45-7:15 a.m.

Continental Breakfast/Registration

 

 

7 :15-7:20

Introduction - Kelly K. Hunt, MD

 

 

7:20-7:50

Keynote Speaker - Jay R. Harris, MD
Breast Cancer Management at the Frontier of Personalized Medicine

 

 

7:50-8:15

Diagnostic Work-Up of the Patient With a Breast Complaint
Wei Yang, MD

 

 

8:15-8:40

What Your Pathology Reports Should Say and How to Interpret Them
Aysegul A. Sahin, MD

 

 

8:40-9:05

Improving Local-Regional Control Impacts Survival
Thomas A. Buchholz, MD

 

 

9:05-9:20

Break

 

 

9:20-9:45

Genetic Testing: When Do We Test and How Do We Counsel Our Patients?
Banu K. Arun, MD

 

 

9:45-10:10

Nipple Sparing Mastectomy: When Is It Appropriate to Offer This to Our Patients?
Kelly K. Hunt, MD

 

 

10:10-10:35

New Agents in Systemic Therapy for Early Stage Breast Cancer
Abenaa Brewster, MD

 

 

10:35-10:45

Break

 

 

10:45-11:10

MRI of the Breast: Who Benefits and How Do We Use It in Practice?
Wei Yang, MD

 

 

11:10-11:35

Evaluation of Micrometastases: How Do We Use the Information Clinically?
Aysegul A. Sahin, MD

 

 

11:35-Noon

Is It Still Important to Perform Lymph Node Dissection on Patients With a Positive Sentinel Node?
Kelly K. Hunt, MD

 

 

Noon-12:15 p.m.

Break and Pick Up Box Lunch

 

 

12:15-12:40

Prognostic and Predictive Markers in Breast Cancer: How Do We Use Them Clinically?
Abenaa Brewster, MD

 

 

12:40-1:05

Partial Breast Irradiation: Who is a Candidate and How Do We Use It in Practice?
Thomas A. Buchholz, MD

 

 

1:05-1:30

Cancer Prevention Strategies in Our Breast Cancer Population
Banu K. Arun, MD

 

 

1:30-2:00

Challenging Breast Cancer Cases Presentation and Interactive Audience Participation
Moderator: Kelly K. Hunt, MD
Breast Faculty Speakers

 

 

2:00

Adjourn


The University of Texas M. D. Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. M. D. Anderson also requires that all
faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.

Agendas are subject to change because we are always striving to improve the quality of your educational experience. M. D. Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth.

Photographing, audio taping and videotaping are prohibited.


© 2009 The University of Texas M. D. Anderson Cancer Center